-
-
-
-
-
-
-
Virax Biolabs completes UK clinical study recruitment ahead of schedule
-
-
-
-
-
-
-
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
-
-
-
-
-
-
-
Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy
-
-
-
-
-
-
-
Virax Biolabs Group (VRAX) Receives Nasdaq Non-compliance Notice
-
-
-
-
-
-
-
Virax Biolabs Group (VRAX) Appoints Nigel McCracken as COO
-
-
-
-
-
-
-
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
-
-
-
-
-
-
-
Virax Biolabs Group (VRAX) Introduces Avian Influenza A Virus Real-Time PCR Test Kit
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

